EUVIMEDObjevte EUVIMED
ÜbersichtsarbeitOpen access

Differences in ion channel phenotype and function between humans and animal models

Mark R Tanner, Christine Beeton

Frontiers in Bioscience · 2018 · 23 (1) · 43-64

DOI: 10.2741/4581 ↗

At a glance

Übersichtsarbeit in Frontiers in Bioscience, 2018. Written by Mark R Tanner and 1 co-authors. Institution: Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston TX 77030, and Interdepartmental Graduate Program in Translatio…. Major MEDLINE topics: Gene Expression Profiling, Mutation. Cited 48 times so far (Crossref). The full text is freely available in PubMed Central. Funded by: NIAMS NIH HHS, NINDS NIH HHS, NIAID NIH HHS.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Ion channels play crucial roles in regulating a broad range of physiological processes. They form a very large family of transmembrane proteins. Their diversity results from not only a large number of different genes encoding for ion channel subunits but also the ability of subunits to assemble into homo- or heteromultimers, the existence of splice variants, and the expression of different regulatory subunits. These characteristics and the existence of very selective modulators make ion channels very attractive targets for therapy in a wide variety of pathologies. Some ion channels are already being targeted in the clinic while many more are being evaluated as novel drug targets in both clinical and preclinical studies. Advancing ion channel modulators from the bench to the clinic requires their assessment for safety and efficacy in animal models. While extrapolating results from one species to another is tempting, doing such without careful evaluation of the ion channels in different species presents a risk as the translation is not always straightforward. Here, we discuss differences between species in terms of ion channels expressed in selected tissues, differing roles of ion channels in some cell types, variable response to pharmacological agents, and human channelopathies that cannot fully be replicated in animal models.

Subjects

MeSH terms (MEDLINE)

Gene Expression ProfilingMutationAnimalsCystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorDisease Models, AnimalGenetic Predisposition to DiseaseHumansIon ChannelsPhenotype

Substances

Ion ChannelsCystic Fibrosis Transmembrane Conductance Regulator

Authors and institutions

  • Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston TX 77030, and Interdepartmental Graduate Program in Translational Biology and Molecular Medicine, Baylor College of Medicine, Housto…
  • Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston TX 77030, and Center for Drug Discovery and Biology of Inflammation Center, Baylor College of Medicine, Houston TX 77030, beeton@bcm…

Funding

  • NIAMS NIH HHS
  • NINDS NIH HHS
  • NIAID NIH HHS
  • NIGMS NIH HHS

Cite

APA

Tanner, M. R., & Beeton, C. (2018). Differences in ion channel phenotype and function between humans and animal models. Frontiers in Bioscience, 23(1), 43-64. https://doi.org/10.2741/4581

Vancouver

Tanner MR, Beeton C. Differences in ion channel phenotype and function between humans and animal models. Frontiers in Bioscience. 2018;23(1):43-64. doi:10.2741/4581

BibTeX
@article{Tanner2018,
  author = {Tanner, Mark R and Beeton, Christine},
  title = {Differences in ion channel phenotype and function between humans and animal models},
  journal = {Frontiers in Bioscience},
  year = {2018},
  volume = {23},
  number = {1},
  pages = {43--64},
  doi = {10.2741/4581}
}
Start for free →